Thrivent Financial For Lutherans Has $549,000 Position in Henry Schein, Inc. (HSIC)
Thrivent Financial For Lutherans boosted its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 3.8% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,000 shares of the company’s stock after acquiring an additional 110 shares during the quarter. Thrivent Financial For Lutherans’ holdings in Henry Schein were worth $549,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also bought and sold shares of HSIC. Lee Financial Co bought a new stake in Henry Schein in the second quarter valued at about $161,000. HM Payson & Co. bought a new stake in Henry Schein in the second quarter valued at about $204,000. Great Lakes Advisors LLC bought a new stake in Henry Schein in the second quarter valued at about $205,000. Wesbanco Bank Inc. bought a new stake in Henry Schein in the second quarter valued at about $205,000. Finally, Delta Capital Management LLC bought a new stake in Henry Schein in the second quarter valued at about $209,000. 44.74% of the stock is currently owned by institutional investors and hedge funds.
COPYRIGHT VIOLATION WARNING: This article was first published by Daily Political and is the sole property of of Daily Political. If you are reading this article on another site, it was stolen and reposted in violation of U.S. and international trademark and copyright legislation. The legal version of this article can be viewed at https://www.dailypolitical.com/2017/10/16/thrivent-financial-for-lutherans-has-549000-position-in-henry-schein-inc-hsic.html.
In related news, SVP Paul Rose sold 2,126 shares of Henry Schein stock in a transaction that occurred on Wednesday, September 6th. The shares were sold at an average price of $172.51, for a total transaction of $366,756.26. Following the sale, the senior vice president now directly owns 17,841 shares of the company’s stock, valued at approximately $3,077,750.91. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 1.19% of the company’s stock.
Shares of Henry Schein, Inc. (NASDAQ HSIC) opened at 80.93 on Monday. The stock’s 50 day moving average is $82.72 and its 200 day moving average is $87.37. The company has a market capitalization of $12.80 billion, a PE ratio of 23.65 and a beta of 1.09. Henry Schein, Inc. has a 1-year low of $73.11 and a 1-year high of $93.50.
Henry Schein (NASDAQ:HSIC) last issued its earnings results on Tuesday, August 8th. The company reported $0.88 EPS for the quarter, beating the consensus estimate of $0.86 by $0.02. The company had revenue of $3.06 billion during the quarter, compared to analysts’ expectations of $3.05 billion. Henry Schein had a net margin of 4.59% and a return on equity of 19.91%. The business’s revenue for the quarter was up 6.4% compared to the same quarter last year. During the same period in the previous year, the company earned $0.82 EPS. On average, equities research analysts anticipate that Henry Schein, Inc. will post $3.64 EPS for the current fiscal year.
Henry Schein announced that its Board of Directors has initiated a stock repurchase plan on Monday, September 18th that authorizes the company to buyback $400.00 million in outstanding shares. This buyback authorization authorizes the company to repurchase up to 6.3% of its shares through open market purchases. Shares buyback plans are generally a sign that the company’s management believes its stock is undervalued.
A number of analysts recently weighed in on the stock. Zacks Investment Research cut shares of Henry Schein from a “buy” rating to a “hold” rating in a research note on Wednesday, August 9th. Northcoast Research raised shares of Henry Schein from a “neutral” rating to a “buy” rating and set a $109.00 price objective on the stock in a research note on Monday, August 7th. BidaskClub cut shares of Henry Schein from a “hold” rating to a “sell” rating in a research note on Wednesday, August 2nd. Jefferies Group LLC reaffirmed a “hold” rating and set a $88.50 price objective on shares of Henry Schein in a research note on Thursday, September 28th. Finally, Credit Suisse Group reaffirmed a “hold” rating and set a $80.00 price objective on shares of Henry Schein in a research note on Thursday, July 13th. One analyst has rated the stock with a sell rating, eleven have issued a hold rating and six have assigned a buy rating to the company’s stock. Henry Schein presently has a consensus rating of “Hold” and an average target price of $92.14.
About Henry Schein
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.